Omeprazole

Active ingredient description

Omeprazole, a racemic mixture of two enantiomers reduces gastric acid secretion through a highly targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell. It is rapidly acting and provides control through reversible inhibition of gastric acid secretion with once daily dosing.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

A02BC01

Omeprazole

A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors

Discover more medicines within A02BC01

Medicines

Omeprazole is the active ingredient of these drugs:

ACIMAX

Australia

AMPRA

Hong Kong

ANTRA MUPS

Germany

ARAPRIDE

Spain

AULCER

Spain

BELIFAX

Tunisia

BYSEC

Ireland

DOLINTOL

Spain

DUDENCER

Hong Kong

ELPRAZOL

Brazil

EPRAZOLE

Hong Kong

EUPEPT

Brazil

EZIPOL

Cyprus Hong Kong

GASEC

Hong Kong Lithuania

GASTER

Hong Kong

GASTOM

Hong Kong

GASTRAL

Tunisia

GASTRIMUT

Spain

GOMEC

Hong Kong

IPPROTON

Tunisia

LICOMEP

Ireland

LOMAC

Hong Kong

LOMICID

Hong Kong

LOSAMEL

Ireland

LOSCID

Hong Kong

LOSEC

Australia Austria Brazil Canada Cyprus

LOSECOSAN

Netherlands

LOSECTIL

Hong Kong

LOZEPREL

Brazil

MAALOX CONTROLE

Tunisia

MAXOR

Australia

MEDOPRAZOLE

Cyprus

MEZZOPRAM

United Kingdom

MOPRAL

France

NEOPRAZOL

Brazil

NEPRAZOL

Brazil

NOCID

Hong Kong

NOGASID

Hong Kong

NOVOPRAZOL

Brazil

NUCLOSINA

Spain

OCID

Singapore

OFNIMAREX

Cyprus

OLEZELA

Lithuania

OLIT

Singapore

OMAPREN

Spain

OMEBETA

Germany

OMEC HEXAL

Austria

OMECAT

Netherlands

OMECID

Hong Kong

OMEDIN

Hong Kong

OMEDIPROL

Lithuania

OMEKAA

Hong Kong

OMEKASTE

Spain

OMENAX

Brazil

OMENOLE

Singapore

OMEPRADEX

Singapore

OMEPRAL

Australia

OMEPRALAN

Austria

OMEPRAMED

Brazil

OMEPRAZIN

Brazil

OMEPROTECT

Spain

OMESEC

Hong Kong Singapore

OMEZOL

Hong Kong Singapore

OMEZOLE

Hong Kong Singapore

OMICAP

Singapore

OMILOCK

Hong Kong

OMIZAC

Hong Kong

OMIZEC

Hong Kong

OMOPREL

Brazil

OMPRANYT

Cyprus

OPRAZON

Brazil

OZMEP

Australia

PARIZAC

Spain

PEDIPPI

Ireland Netherlands

PEMZO

Australia

PENRAZOL

Cyprus Singapore

PEPTICUM

Spain

PRATIPRAZOL

Brazil

PRILOSEC

United States

PROBITOR

Australia Singapore

PROCEPTIN

Singapore

PROMESEC

Singapore

PUMPITOR

Singapore

PYLORID

Hong Kong

PYROCALM

United Kingdom

RAMEZOL

Singapore

REDUSEC

Hong Kong

REMEPRAZOLE

Cyprus

REMOSTAR

Lithuania

ROMESEC

Singapore

SOLCER

Singapore

TEUTOZOL

Brazil

ULCERAL

Spain

ULCESEP

Spain

ULTOP

Lithuania

ULZAC

Lithuania

VICKOSEC

Hong Kong

VICKSEC

Hong Kong

ZENPRO

Hong Kong Singapore

ZIGACAP

Hong Kong

ZIMOR

Singapore

ZOLTUM

France

Omeprazole is also found within below combination drugs:

ARTHROCOMB , CECLOVA , DICLODUO COMBI , DIOMPRAZ , OMEPRAMIX , PROFENID PROTECT , TALICIA , YOSPRALA , ZEGERID

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

OMEPRAZOLE Gastro-resistant capsules

Summary of product characteristics (SPC)

PRILOSEC Granule for delayed-release oral suspension

Structured product labeling (SPL/PLR)

OMEPRAZOLE Powder for solution for infusion

Summary of product characteristics (SPC)

Next: Usage

Omeprazole

Active ingredient description

Medicine classification

Medicines

Product monographs

Structural formula

3D molecular structure

Unique ingredient identifier (UNII)

CAS registry number

SNOMED-CT